Group 1 - The core point of the news is that Anbiping's stock price dropped by 5.32% to 30.26 CNY per share, with a trading volume of 96.7 million CNY and a turnover rate of 3.33%, resulting in a total market capitalization of 2.831 billion CNY [1] - Anbiping, established on July 6, 2005, and listed on August 20, 2020, is primarily engaged in the research, production, and sales of in vitro diagnostic reagents and instruments [1] - The revenue composition of Anbiping includes 79.72% from self-produced products, 13.11% from purchased products, 5.90% from service income, and 1.27% from other sources [1] Group 2 - Longcheng Consumption Value Mixed A Fund (200006) is among the top ten circulating shareholders of Anbiping, holding 850,000 shares, which is unchanged from the previous period, representing 0.91% of the circulating shares [2] - The fund has incurred an estimated floating loss of approximately 1.445 million CNY today [2] - Longcheng Consumption Value Mixed A Fund was established on April 6, 2006, with a current scale of 516 million CNY, and has achieved a year-to-date return of 21.73%, ranking 56 out of 8,847 in its category [2]
安必平股价跌5.32%,长城基金旗下1只基金位居十大流通股东,持有85万股浮亏损失144.5万元